What did @kingtolo17 actually say?
The creator argued that combining testosterone (via TRT or a cycle) with MK-677 creates "astronomical" synergy because testosterone and growth hormone are two separate optimization targets. He described MK-677 as something that "tells the pituitary gland to release more growth hormone" and listed benefits including fat burning, anti-aging effects, better sleep, recovery, muscle tone, and stronger lifts. The framing was that you want both hormones "optimized" simultaneously.
To be fair, the core mechanism he described is roughly correct. MK-677 (ibutamoren) is a ghrelin receptor agonist that does stimulate pituitary GH secretion. That part is not made up. But the leap from "mechanism exists" to "the synergy is astronomical" is where things start to unravel.
Does the science back this up?
Partially, but not the way he implies. The evidence for MK-677 on GH and IGF-1 elevation is real but limited, and the "synergy" with exogenous testosterone is largely extrapolated from bodybuilding culture, not controlled trials.
MK-677 does raise GH and IGF-1 in humans. Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) confirmed sustained IGF-1 increases over two years in older adults, with modest improvements in lean mass. Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed improved sleep quality and slow-wave sleep, which is the one benefit claim here that has decent backing.
The fat-burning claim is weaker. Most studies show body composition changes are modest and often accompanied by increased appetite and insulin resistance. The "anti-aging" framing has almost no rigorous support in humans. And the idea that stacking it with testosterone produces compounding benefits? There is no published clinical trial testing that specific combination.
What did they get wrong (or right)?
He got the basic mechanism right. MK-677 acts on the ghrelin receptor to stimulate GH release from the pituitary. That is accurate. The sleep benefit has real data behind it.
What he got wrong, or at minimum oversold, is significant. Calling the synergy "astronomical" implies a level of evidence that does not exist. MK-677 is not approved by the FDA for any indication. It is classified as an investigational compound. Describing it casually alongside TRT as a lifestyle optimization stack glosses over real safety concerns: water retention, increased fasting glucose, potential tumor promotion in IGF-1 sensitive tissues, and cardiovascular strain when combined with supraphysiologic testosterone.
The phrase "anti-aging" is doing a lot of unearned work here. The geroscience community has not endorsed GH secretagogues as aging interventions. Bartke (2019, Neuroendocrinology) has actually argued that lower IGF-1 signaling correlates with longevity in multiple species, which is the opposite of what this stack does.
What should you actually know?
MK-677 is not a supplement in any regulated sense. It is an investigational drug that has never completed Phase III trials and is not legal to sell as a dietary supplement in the United States. Most products labeled as MK-677 on the market are sold in a legal gray zone and carry no quality guarantees.
If you are on physician-supervised TRT for diagnosed hypogonadism, adding an unapproved compound without medical supervision introduces risks your prescribing doctor cannot monitor or account for. Elevated IGF-1 from MK-677 can worsen insulin sensitivity, which is already a concern with testosterone therapy. Anyone with a family history of hormone-sensitive cancers should treat this combination with serious caution.
The benefits he describes, better sleep, recovery, and muscle gains, do have some scientific basis individually, but the magnitude he implies and the safety profile he ignores make this video incomplete at best and misleading at worst.